In December 2005, Eli Lilly and Corporation agreed to plead guilty and shell out $36 million in reference to the illegal promotion of the drug.[264] Gross sales Reps had been trained to market Evista for breast most cancers and heart problems, to prompt or bait queries by Medical doctors, also t